Glenmark Pharma launches Travoprost ophthalmic solution in US

Share it

Glenmark Pharma Share Price | Travoprost Ophthalmic Solution USP, 0.004%, is used to lower intraocular pressure in patients with ocular hypertension or open-angle glaucoma, the company said. 

Leave a Comment

Your email address will not be published. Required fields are marked *